Phase IIb ARISE study of padsevonil does not reach statistical significance for primary endpoints March 16, 2020
Chlorotoxin-CAR T cells specifically targeting glioblastomas shows preclinical antitumor activity March 16, 2020
Aclaris initiates phase IIa study of ATI-450 with methotrexate for moderate to severe RA March 16, 2020
FDA approves Opdivo plus Yervoy for the treatment of HCC previously treated with sorafenib March 13, 2020
RSS